@article{ATM33628,
author = {Suguru Kadomoto and Tomoyuki Makino and Kouji Izumi and Atsushi Mizokami},
title = {An important step in establishing a treatment strategy for small renal masses of clear cell renal cell carcinoma based on the significance of adverse histopathologic features on tumor needle biopsy},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 8},
year = {2019},
keywords = {},
abstract = {Renal cell carcinoma (RCC) accounts for 3–4% of all adult cancer cases in the United States, and is divided into two groups: clear cell RCC (CCRCC) and non-CCRCC (1,2). CCRCC is the most dominant histological phenotype that accounts for 70–80% of all RCC cases. A total of 20–40% of patients with RCC experience metastatic or recurrent disease after a primary surgery [nephrectomy or partial nephrectomy (PN)], and approximately 50% of patients with RCC eventually receive systemic medication during their disease course (2).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/33628}
}